You just read:

Medison to Nominate Six Highly Qualified Directors for Knight Therapeutics' Board to Strengthen Oversight and Drive Value Creation for All Shareholders

News provided by

Medison Biotech Ltd.

Apr 01, 2019, 08:00 ET